Knowledge Base

Does the Risk management systems need to be updated regularly?

21 December 2023
2 min read

If the applicant / marketing authorisation holder has submitted an RMP for the product, the RMP submitted later should adopt an updated format. Each RMP submitted shall have a unique version number and date. There is no specific time requirement for the regular RMP update, and RMP is usually required in the following cases: first, the regulatory authority requires the update; The second is the modification of the risk management system, especially the modification caused by the receipt of information that may lead to important changes in the balance of risk and benefit, or as important pharmacovigilance, or reaching risk minimization milestones. (EMA GVP module v-risk management systems (Rev 2))

Wugen Reveals Early Data on WU-CART-007 for Tough Blood Cancers at Annual American Hematology Conference
Latest Hotspot
3 min read
Wugen Reveals Early Data on WU-CART-007 for Tough Blood Cancers at Annual American Hematology Conference
21 December 2023
Wugen Unveils Initial Results from Early-Stage Clinical Assessment of WU-CART-007 in Hard-to-Combat Hematologic Malignancies at the Yearly American Hematology Conference.
Read →
Understanding RIPK1 Inhibitors and Methods to Keep Abreast of Their Recent Developments
Understanding RIPK1 Inhibitors and Methods to Keep Abreast of Their Recent Developments
21 December 2023
RIPK1 inhibitors are drugs that target the enzyme RIPK1, crucial in cell death and inflammation regulation.
Read →
Connect Biopharma reports positive Phase 2b results for Rademikibart in moderate to severe adult asthma
Latest Hotspot
3 min read
Connect Biopharma reports positive Phase 2b results for Rademikibart in moderate to severe adult asthma
21 December 2023
Connect Biopharma has revealed encouraging primary outcomes from its global Phase 2b trial of Rademikibart in treating adults with moderate to severe chronic asthma.
Read →
What is post marketing research?
"What" Series
2 min read
What is post marketing research?
21 December 2023
post marketing research of drugs refers to the research on the use and effect of drugs following a specific research scheme after they are approved for marketing.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.